Invasive aspergillosis in pediatric patients

References

• Chandrasekar PH, Cutright JL, Manavathu EK. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994–1999. Diagn Microbiol Infect Dis 2001;41:211-14
   PubMed Web of Science ®Google Scholar
• Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32
   PubMed Web of Science ®Google Scholar
• Lass-Florl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009;52:197-205
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-17
   PubMed Web of Science ®Google Scholar
• Steinbach WJ. Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J 2005;24:358-64
   PubMed Web of Science ®Google Scholar
• McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis 2001;33:641-7
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Heydon K, Chu JH, et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006;117:e711-16
   PubMed Web of Science ®Google Scholar
• Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 2009;52:206-22
   PubMed Web of Science ®Google Scholar
• Dotis J, Iosifidis E, Roilides E. Central nervous system aspergillosis in children: a systematic review of reported cases. Int J Infect Dis 2007;11:381-93
   PubMed Web of Science ®Google Scholar
• Crassard N, Hadden H, Piens MA, et al. Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 2008;51:109-16
   PubMed Web of Science ®Google Scholar
• Patterson TF, Kirkpatrick WR, White IM, et al. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. I³ Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-60
   PubMed Web of Science ®Google Scholar
• Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008;127:286-97
   PubMed Web of Science ®Google Scholar
• Camps IR. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Int J Antimicrob Agents 2008;32(Suppl. 2):S119-23
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002;100:4358-66
   PubMed Web of Science ®Google Scholar
• Mikulska M, Raiola AM, Bruno B, et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009;44:361-70
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation – focus on aspergillosis. Clin Chest Med 2009;30:295-306,vii
   PubMed Web of Science ®Google Scholar
• Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84
   PubMed Web of Science ®Google Scholar
• Auletta JJ, Cooke KR. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 2009;21:30-8
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis 2009;22:376-84
   PubMed Web of Science ®Google Scholar
• Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994;140(pt 9):2475-9
   Google Scholar
• Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999;29:1210-19
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008;177:27-34
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16
   PubMed Web of Science ®Google Scholar
• Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008;47:1176-84
   PubMed Web of Science ®Google Scholar
• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-66
   PubMed Web of Science ®Google Scholar
• Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008;121:e1286-94
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Walsh TJ. Mycoses in pediatric patients. Infect Dis Clin North Am 2006;20:663-78
   PubMed Web of Science ®Google Scholar
• Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs 2007;67:269-98
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60
   PubMed Web of Science ®Google Scholar
• Thomas L, Baggen L, Chisholm J, et al. Diagnosis and treatment of aspergillosis in children. Expert Rev Anti Infect Ther 2009;7:461-72
   PubMed Web of Science ®Google Scholar
• Abramson S. The air crescent sign. Radiology 2001;218:230-2
   PubMed Web of Science ®Google Scholar
• Brodoefel H, Vogel M, Hebart H, et al. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. AJR Am J Roentgenol 2006;187:404-13
   PubMed Web of Science ®Google Scholar
• Verdaguer V, Walsh TJ, Hope W, et al. Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn 2007;7:21-32
   PubMed Web of Science ®Google Scholar
• Petraitiene R, Petraitis V, Groll AH, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother 2001;45:857-69
   PubMed Web of Science ®Google Scholar
• Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002;34:939-43
   PubMed Web of Science ®Google Scholar
• Miceli MH, Grazziutti ML, Woods G, et al. Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 2008;46:1412-22
   PubMed Web of Science ®Google Scholar
• Wheat LJ. Approach to the diagnosis of invasive aspergillosis and candidiasis. Clin Chest Med 2009;30:367-77,viii
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004;190:641-9
   PubMed Web of Science ®Google Scholar
• Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006;44:389-94
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20:1898-906
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91:311-18
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007;26:558-64
   PubMed Web of Science ®Google Scholar
• Hayden R, Pounds S, Knapp K, et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J 2008;27:815-19
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother 2004;48:2166-72
   PubMed Web of Science ®Google Scholar
• Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother 2009;53:935-44
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Mousset S, Sorensen J, et al. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach. Mycoses 2009;52:107-17
   PubMed Web of Science ®Google Scholar
• Diflucan [package insert]. New York, NY: Pfizer, Inc., 2008
   Google Scholar